Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:834986rdf:typepubmed:Citationlld:pubmed
pubmed-article:834986lifeskim:mentionsumls-concept:C0062524lld:lifeskim
pubmed-article:834986lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:834986lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:834986lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:834986lifeskim:mentionsumls-concept:C0454664lld:lifeskim
pubmed-article:834986pubmed:issue5lld:pubmed
pubmed-article:834986pubmed:dateCreated1977-3-31lld:pubmed
pubmed-article:834986pubmed:abstractTextUsing a solid phase radioimmunoassay, prevalence of anti-HA was determined in sera of 661 German patients treated following accidents, 70 persons born in Mediterranean countries and 175 persons from Lillehammer, Norway. In Germany (55% positive) an increase in prevalence of anti-HA from 13% in the group below 20 years of age to 92% in persons over 49 was noted. This and further data suggest that after infection anti-HA is detectable for life. Persons from Norway (17% positive) aged below 40 years had a low prevalence of anti-HA (4-10%), whereas even young persons from Mediterranean countries (81% positive) hat antibody in about 80% of cases. Prevalence rates in different age groups suggest a remarkable decrease in incidence of hepatitis A infection over the last three decades in Germany. This results in a rise in the mean age at which hepatitis A infection is acquired and high morbidity during travel abroad. Only one of 10 hepatitis A infections appears to produce clinical disease. Young anti-HA positive individuals exhibit higher titers on average than older ones.lld:pubmed
pubmed-article:834986pubmed:languagegerlld:pubmed
pubmed-article:834986pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:834986pubmed:citationSubsetIMlld:pubmed
pubmed-article:834986pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:834986pubmed:statusMEDLINElld:pubmed
pubmed-article:834986pubmed:monthFeblld:pubmed
pubmed-article:834986pubmed:issn0036-7672lld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:SchneiderWWlld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:HaasHHlld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:DietzKKlld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:FrösnerG GGGlld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:FrösnerH RHRlld:pubmed
pubmed-article:834986pubmed:authorpubmed-author:SugiSSlld:pubmed
pubmed-article:834986pubmed:issnTypePrintlld:pubmed
pubmed-article:834986pubmed:day5lld:pubmed
pubmed-article:834986pubmed:volume107lld:pubmed
pubmed-article:834986pubmed:ownerNLMlld:pubmed
pubmed-article:834986pubmed:authorsCompleteYlld:pubmed
pubmed-article:834986pubmed:pagination129-33lld:pubmed
pubmed-article:834986pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-H...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-H...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-N...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-A...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-G...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-M...lld:pubmed
pubmed-article:834986pubmed:meshHeadingpubmed-meshheading:834986-A...lld:pubmed
pubmed-article:834986pubmed:year1977lld:pubmed
pubmed-article:834986pubmed:articleTitle[Frequency of hepatitis A antibodies in populations of various European countries].lld:pubmed
pubmed-article:834986pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:834986pubmed:publicationTypeEnglish Abstractlld:pubmed